This is supported by the fact that, when using the full set of AD genetic instruments minus APOE, point estimates remained largely unchanged but confidence intervals were wider (Supplementary Table L, available as Supplementary data at IJE online). The gene discussed is APOE; the disease is Alzheimer disease.